CC
PTCT icon

Centiva Capital’s PTC Therapeutics PTCT Stock Holding History

Centiva Capital’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11,607
Closed -$550K – 1583
2021
Q1 		$550K Buy
+11,607
New +$689K 0.02% 524
2020
Q4 		– Sell
-4,359
Closed -$204K – 1068
2020
Q3 		$204K Buy
+4,359
New +$215K 0.01% 597
2019
Q4 		– Sell
-12,139
Closed -$411K – 906
2019
Q3 		$411K Buy
+12,139
New +$528K 0.03% 373

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Centiva Capital's PTCT Position: Q2 2021 in Review

Centiva Capital sold out of PTC Therapeutics (PTCT) in Q2 2021, closing a stake of 11,607 shares — an estimated $550K sold.

Centiva Capital first reported a position in PTCT in Q3 2019 and held it in 3 quarters. The position peaked at $550K in Q1 2021. 183 funds tracked by Wall St. Rank hold PTCT as of Q2 2021.

  • Centiva Capital reported no remaining PTC Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Centiva Capital sold 11,607 PTC Therapeutics shares in Q2 2021, an estimated $550K.
  • Centiva Capital first reported a position in PTC Therapeutics in Q3 2019 and held it in 3 quarters.
  • Centiva Capital's PTC Therapeutics position peaked at $550K in Q1 2021.
  • 183 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2021.

Based on Centiva Capital's 13F filing for Q2 2021, filed 16 Aug 2021.